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In Brief
Hu et al. demonstrate the importance of persistent expression of VCAM1 in RGCs while they switch from an active proliferative state to a quiescent state. The function of VCAM1 is time and location dependent through the GSK3b/ b-catenin pathway.
INTRODUCTION
Neural stem cells (NSCs) exist widely in the embryonic nervous system, but become restricted to two major neurogenic niches in the adult rodent brain: the ventricular-subventricular zone (V-SVZ) in the lateral ventricular wall and the subgranular zone (SGZ) in the dentate gyrus of the hippocampus (Bond et al., 2015; Gage and Temple, 2013; Lim and Alvarez-Buylla, 2016) . NSCs first appear as neuroepithelial cells lining the ventricular lumen and divide symmetrically to expand the progenitor cell pool. As more neuroepithelial cells build up the thickening pseudostratified ventricular wall, these cells elongate and convert into radial glial cells (RGCs), which generate neurons directly or indirectly via intermediate progenitor cells (IPCs) . In the dorsal telencephalon, RGCs convert into ependymal cells and astrocytes after cortical neurogenesis ends, while a subpopulation of RGCs in the ventral telencephalon gives rise to the specialized B1 astrocytes in the V-SVZ, the adult neural stem/progenitor cells (Gaiano et al., 2000; Gao et al., 2014; Gö tz and Huttner, 2005; Kriegstein and Alvarez-Buylla, 2009; Spassky et al., 2005; Tramontin et al., 2003) . Lineage-tracing studies have demonstrated the lineal progression of NSCs from neuroepithelial cells to RGCs to adult B1 cells and a direct link between embryonic NSCs and postnatal/adult NSCs (Fuentealba et al., 2015; Furutachi et al., 2015; Merkle et al., 2004) . Interestingly, these studies show that pre-B1 cells arise from a distinct subpopulation of RGCs during embryonic development. The pre-B1 RGCs become slowly dividing at around embryonic day (E) 13.5-15.5, while other RGCs still divide rapidly (Furutachi et al., 2015) . This observation raises the question of what mechanisms govern the specification and maintenance of this quiescent population of NSCs from embryo to adulthood.
Adult B1 NSCs maintain contact to the ventricle via apical processes that form the center of the characteristic pinwheel-like organization of cells in the ependymal layer (Mirzadeh et al., 2008; Shen et al., 2008) . We previously found that vascular cell adhesion molecule 1 (VCAM1), a cell-surface sialoglycoprotein belonging to the immunoglobin (Ig) superfamily (Osborn et al., 1989; Pepinsky et al., 1992) , is localized in the center of the ependymal pinwheel structure and enriched on the apical endfeet of quiescent B1 cells in the adult V-SVZ (Kokovay et al., 2012) .
Expression profiling studies of adult V-SVZ cells have also shown that VCAM1 is highly expressed in quiescent NSCs (Codega et al., 2014; Llorens-Bobadilla et al., 2015) . Blocking VCAM1 resulted in activation of these cells, indicating that VCAM1 maintains adult NSCs in a quiescent state (Kokovay et al., 2012) .
In this study, we investigated the expression of VCAM1 in the mouse forebrain over the entire neurogenic period. We found that the developmental profile of VCAM1 is correlated with progression of NSC identity. Conditional deletion of VCAM1 in the embryonic brain using either Emx1-Cre or Nestin-Cre mouse lines caused RGCs to differentiate during mid-gestation, diminishing the population of NSCs that become slowly dividing in the embryo. Loss of VCAM1 in the embryo also reduced the thymidine analog bromodeoxyuridine (BrdU)-label-retaining cells (BrdU-LRCs) and regeneration in the adult V-SVZ. We further revealed that VCAM1 inhibits GSK3b, maintaining b-catenin signaling in active cortical RGCs, while it represses b-catenin signaling in the striatal V-SVZ at later embryonic stages through a GSK3b-independent pathway. Hence, VCAM1 is required for preservation of the embryonic RGCs to the adult stage, maintaining the NSC properties through a stage-and region-dependent mechanism.
RESULTS

VCAM1 Is Expressed in RGCs in the Developing Forebrain
In the embryonic telencephalon, VCAM1 mRNA and protein were detected by in situ hybridization and western blot, respectively (Figures S1A and S1B). To further examine the temporal expression pattern of VCAM1, we immunostained brain sections from the beginning of neurogenesis (E11) through the early postnatal period (P7). VCAM1 protein was first detected at a very low level in the lateral ganglionic eminence (LGE) at E11.5, while in the cortical primordium VCAM1 was barely visible by E12.5. The expression level increased in the ventricular zone (VZ) and became enriched on the apical side of the VZ over time. After birth, the level of VCAM1 expression dramatically decreased in the neocortex and became more restricted to the striatal side of the lateral ventricle ( Figures 1A and S1C ). VCAM1-expressing cells were positive for RGC markers p-Vimentin, Pax6, Nestin, and BLBP, with radial fibers extending basally toward the pial surface, but much less for IPC marker Tbr2, confirming their RGC identity ( Figures 1B and 1C) . VCAM1 was also detected in Nestin+ cells in cultured cortical neurospheres in vitro, more concentrated on the contacting interface between adjacent cells (Figures S1D and S1E).
As the membrane and process-associated VCAM1 staining precluded accurate quantification in the highly crowded VZ and SVZ region, we performed immunostaining with a variety of cell fate markers on acutely isolated single cells to better quantitatively assess the cell types expressing VCAM1, an approach that can greatly facilitate colocalization analysis (Gaiano et al., 2000; Hartfuss et al., 2001) . The majority of VCAM1-expressing cortical cells were positive for the progenitor cell markers Nestin, SOX2, BLBP, Pax6, and LeX ( Figures 1D-1F and S1F). In contrast, less than 20% of cortical VCAM1+ cells were Tbr2+ (IPCs), and almost none were doublecortin+ (DCX, a newborn neuron marker). In the GE, more than 60% of VCAM1+ cells were Nestin+ and around 40% were LeX+ at E16 ( Figure S1H ). However, in both cortical and GE cells, VCAM1 only labeled 20%-50% of neural progenitor cells, indicating it is selectively expressed in a subpopulation (Figures S1F-S1I).
VCAM1 Expression Is Sustained in the Embryonic Slowly Dividing Cells and in the Postnatal NSCs
We further examined the expression pattern of VCAM1 on the VZ surface using the wholemount preparation, which gives an en-face view of the apical surface. At E13.5 VCAM1 was distributed around the cell membrane, close to junctional b-catenin ( Figures S2A-S2G ). Nearly all cells on the VZ surface were VCAM1+, including mitotic cells revealed by phospho-histone H3 (pH3) staining ( Figures S2A-S2G ). This pattern changed dramatically after birth. At P0, the en-face view of the GE ventricular surface illuminated strong VCAM1 expression on the VZ surface, although some cells already lost VCAM1 expression ( Figure 2A ). By P7, chains of VCAM1+ cells were separated by ependymal cells, which were much bigger in size than VCAM1+ cells. The VCAM1+ cells became sparser at P14, and by P21 these cells were restricted to the center of the ''pinwheels'' outlined by b-catenin staining ( Figure 2A and Movies S1, S2, S3, and S4), reminiscent of the adult expression patterns. Hence, progressively restricted VCAM1 expression is maintained in RGCs as they undergo transition from the embryonic to the adult state, but lost in the neighboring ependymal cells as they mature.
The transition of embryonic RGCs to the adult stage is accompanied by changes in lineage potential and proliferating status (Fuentealba et al., 2015; Furutachi et al., 2015) . As the expression of VCAM1 is persistent from the embryonic RGCs to the adult quiescent NSCs, we examined whether VCAM1-expressing cells become quiescent during embryonic development. Interestingly, the percentage of dividing VCAM1+ cells changed differentially in the cerebral cortex versus in the GE. At E12.5, in both the cortex and GE, nearly 80% of acutely stained VCAM1+ cells were Ki67+. However, as most cortical VCAM1+ cells were proliferating at E16.5, the percentage of dividing VCAM1+ cells in GE dramatically decreased. Among the actively dividing progenitor cells (LeX+ or Ki67+), VCAM1+ cells were also less in the GE than that in the cortex at E16 ( Figure S2H ). Indeed, in RC2+Ki67+ dividing RGCs, less than 10% were VCAM1+, while in RC2+Ki67À cells, more than 30% were VCAM1+ ( Figure S2I ). After birth, nearly 95% of VCAM1+ cells in GE were no longer Ki67+ ( Figure 2B ). Notably, we observed that there was a dramatic decrease of Ki67+ cells from E15.5 to E17.5 along the apical surface of the VZ region in the GE (which we call apical Ki67+ cells), where VCAM1 was highly enriched ( Figure 2C , from 11 to 7 per 100 mm of the apical surface length), suggesting VCAM1-expressing cells became less dividing in vivo.
To further confirm that VCAM1 is expressed in slowly dividing pre-B1 cells, we injected BrdU 4 times with 2-hr intervals at E10.5 and sacrificed embryos at E17.5, which labels slowly dividing progenitor cells, as described by Furutachi et al., 2015. BrdU label retention was detected in the VCAM1+ cells along the ventricular surface in the LGE region ( Figure 2D ). We also repeatedly injected BrdU into timed pregnant mice once per day for 3 days from E15.5 to E17.5, when the embryonic origin of the adult NSC diverges from active dividing progenitor cells, and examined the GE V-SVZ at P21 ( Figure 2E ). At this stage, VCAM1 expression was only found in the GFAP+ cells along the VZ wall that have radial processes extending toward the striatal side. Most VCAM1+GFAP+ cells were BrdU-LRCs at the apical surface of V-SVZ ( Figure 2F ; more than 70% of VCAM1+ were BrdU-LRCs), and the VCAM1+BrdU+ cells were not Ki67+ (Figure S2J) , confirming that VCAM1+ cells are slowly dividing pre-B1 cells. Consistent with the result that ependymal cells are generated during E14.5-E16.5 (Spassky et al., 2005) , we found that 10%-20% of BrdU-LRCs were positive for ependymal cell marker S100b ( Figure S2K ). Because VCAM1 expression was mainly on the endfeet that protrude between the S100b+ ependymal cells, it is difficult to completely exclude the possibility of co-labeling of VCAM1 and S100b in some cells at this resolution. Nonetheless, we found that nearly 90% of VCAM1+ cells were clearly S100bÀ, and more than 94% of S100b+ cells were VCAM1À ( Figure 2G ), indicating VCAM1+ cells are unlikely mature ependymal cells.
To examine whether embryonic VCAM1-expressing cells give rise to postnatal NSCs, we electroporated a VCAM1 promoter-driven Cre-IRES-GFP plasmid into the LGE of E14.5 or E16.5 Ai9-tdTomato (TdT) reporter mouse ( Figure S2L ). At P28, we found recombined TdT+ cells in the olfactory bulb (OB), rostral migratory stream (RMS), striatum, and SVZ region. TdT+ cells in the OB extended long processes from the granule layer to the periglomerular layer. Many TdT+ cells in the SVZ were GFAP+ and SOX2+, and a subset of these cells were still GFP+, suggesting that VCAM1-expressing cells generate NSC lineage cells and maintain as postnatal NSCs ( Figures 2H-2J ).
Acute Silencing of VCAM1 and Altered Intracellular Domain of VCAM1 in RGCs Promote Lineage Progression and Differentiation To determine the function of VCAM1 during RGC development, we performed in utero electroporation (IUE) with a Cre-GFP plasmid into cortical RGCs of E14.5 VCAM1 fl/fl mouse embryos, which leads to acute deletion of VCAM1 in electroporated cells. The embryos were collected at E16.5, 2 days post-IUE (DPI), and examined by immunostaining. We found a significant decrease in the number of Ki67+ cells in the deletion group compared to control (a plasmid carrying DCre, an inactive form of Cre recombinase) ( Figures 3A and 3B ). The percentage of Pax6+ cells in GFP+ cells also decreased (control, 21.6% ± 2.4%; Cre-VCAM1-KO, 16.3% ± 3.1%), while Tbr2+ cells increased (12.5% ± 0.5% to 19.8% ± 2.1%) ( Figures 3C and  3D ). Knockdown of VCAM1 by IUE of an shRNA construct against VCAM1 (V-sh) led to similar reduction in Ki67+ and Pax6+ cells in the cortical VZ/SVZ ( Figures S3A-S3F ). There were more GFP+ cells leaving the VZ/SVZ and entering the intermediate zone (IZ) after VCAM1 knockdown (Figure S3G and S3H) . Using a neuronal differentiation indicator construct, pNeuroD1-mCherry, we found that V-sh increased the percentage of pNeuroD1-mCherry+ cells (Figures 3E and 3F ; 48.4% ± 7.6% compared to 29.2% ± 5.4% in control). Furthermore, two constructs with altered VCAM1 intracellular domains, DCyt19 and S730A, mimicked the effect of V-sh knockdown. DCyt19 is a truncated form of VCAM1, which lacks the 19 amino acids of the intracellular domain of VCAM1, and S730A is a point mutation in VCAM1, in which the serine (S) at site 730 is mutated into alanine (A) ( Figure 3G ). The S730 site is important for VCAM1 intracellular signal transduction (Marchese et al., 2012) and can be phosphorylated (Ullah et al., 2016) . Both DCyt19 and S730A constructs significantly reduced Ki67+GFP+ cells in the cortical VZ/SVZ at E16.5 ( Figures 3H and 3I ). Concordantly, co-IUE of pNeuroD1-mCherry with DCyt19 or S730A showed that both DCyt19 and S730A increased the percentage of mCherry+ neuronal cells in the GFP+ cells in the VZ/SVZ region ( Figures S3I and S3J ). These results suggest that VCAM1 acts through its intracellular domain in cortical RGCs and the S730 residue is important for mediating VCAM1 intracellular signaling.
We also performed IUE in the LGE to acutely delete VCAM1 in ventral RGCs. Cre-GFP or DCre-GFP plasmids were electroporated into the LGE region of the VCAM1 fl/fl mouse embryos at E14.5, and forebrain sections were examined at E16.5. We found that the percentage of total Ki67+GFP+ cells was significantly reduced in the Cre-GFP group (12.6% ± 2.0%) compared to the DCre-GFP group (control, 40.4% ± 5.5%) ( Figures 3J and 3K ). The reduction in Ki67+GFP+ cells mainly occurred at the apical side ( Figure S3K ). The percentage of GFP+ cells that were positive for SOX2, which labels GE RGC similar to Gsx2 at this stage (data not shown), was also decreased (Figures 3J and 3L) . Ascl1 staining, which labels active and more differentiated proliferating progenitor cells, revealed that the percentage of Ascl1+GFP+ was not significantly changed ( Figures 3J and 3L ), but we noticed that more Cre-GFP+ cells moved past the Ascl1+ band into the striatal parenchyma than control ( Figure S3L ). Hence, acute deletion of VCAM1 in the GE reduced apical RGCs and led to accelerated lineage progression.
These results indicated that VCAM1 is required for maintaining proliferative RGCs in both cortical and LGE regions. In vitro neurosphere assay and adherent clonal assay also confirmed that loss of VCAM1 impaired NSC self-renewal and promoted differentiation of both cortical and GE cells ( Figure S4 ). 
(legend continued on next page)
Conditional Deletion of VCAM1 in Cortical Progenitor Cells Reduced RGCs and Upper-Layer Neuron Production through Premature Cell-Cycle Exit As VCAM1 knockout mice die during embryogenesis (Gurtner et al., 1995) , to elucidate the function of VCAM1 in embryonic RGCs in vivo, we generated conditional VCAM1 knockout mouse lines using the Cre-loxP system by crossing VCAM1
fl/fl mice with two Cre mouse lines: Emx1-Cre and Nestin-Cre (STAR Methods). We confirmed the specific Cre recombination and deletion of VCAM1 in these two lines ( Figures S5A-S5D ).
In the Emx1-Cre/VCAM1 fl/fl mouse line (designated as EVcKO), VCAM1 was specifically deleted in the cerebral cortex and hippocampus, while in Nestin-Cre/VCAM1 fl/fl embryos (designated as NV-cKO), VCAM1 protein was undetectable in both dorsal and ventral brain when examined. The survival, fertility, or body weight of the adult cKO mice was similar to that of wild-type. There was no discernible gross morphological and growth abnormality in cKO mice (data not shown).
We stained the brain sections for the RGC marker Pax6 and found that the number of Pax6+ cells was significantly reduced in the EV-cKO cortex at E15.5 compared to control (Figures 4A and 4B) . This was accompanied by a reduction in the number of Ki67+ cells in the cortical VZ/SVZ of E15.5 EV-cKO mouse embryos compared to control ( Figures 4D and 4E ), without a significant difference in Caspase3+ cells (not shown). The number of Tbr2+ cells was not significantly changed ( Figure 4C ), and there was no difference in Tbr2+Ki67+ cell number (17.3% ± 1.9% for wild-type and 20.7% ± 4.0% for EV-cKO), suggesting that loss of VCAM1 reduces RGCs but does not affect proliferation of Tbr2+ IPCs.
As the reduction in Pax6+ and Ki67+ cells occurred at the stage of upper-layer neuron generation, we quantified the upper-layer neuron production by measuring Cux1+ layer thickness in the P7 cerebral cortex, when migration of cortical projection neurons nearly finished. We found that the Cux1+ layer in EV-cKO was significantly thinner than that in control ( Figures  4J and 4K) . Indeed, the number of upper-layer neurons born at E17 determined by BrdU labeling was greatly reduced in EVcKO compared to control ( Figure 4L ). The reduction in thickness of Cux1+ layer persisted to the adult ( Figure S5E ).
To determine whether loss of VCAM1 impacts cell-cycle exit of RGCs, we injected BrdU into timed-pregnant mice 24 hr before sacrifice. The brain sections were co-stained for BrdU and Ki67, and the cell-cycle exit index was calculated as the ratio of BrdU+Ki67À/BrdU+Ki67+. We found that deletion of VCAM1 increased the cell-cycle exit index in cortical RGCs ( Figures 4F-4I , S5F, and S5G). Similarly, we found that the cell-cycle exit index was increased in the LGE of NV-cKO brain compared to control (0.70 ± 0.05 to 1.23 ± 0.04, Figures 4M  and 4N ). As BrdU labels the dividing cells at the time of injection, these results suggest that in the absence of VCAM1, actively dividing cells undergo lineage progression and differentiation. Hence, VCAM1 depletion during mid-gestation caused premature cell-cycle exit, leading to a reduction in dividing RGCs.
Loss of VCAM1 Reduces Slowly Dividing Cells in the Embryonic GE and Leads to a Decrease in NSCs in the Postnatal V-SVZ The above experiments indicate that VCAM1 is required for maintaining RGCs when they are actively dividing. As VCAM1 is persistent in the slowly dividing embryonic origin of postnatal NSCs (Figure 2 ), we further investigated whether VCAM1 is functionally relevant to this population. Interestingly, the apical Ki67+ cells were dramatically increased in the LGE of the NV-cKO brain at both E17.5 and E18.5 compared to control (Figures 4O, 5A, and 5B) . Nearly all of the apical Ki67+ cells were SOX2+, while less than 2% of those were Ascl1+ ( Figure S5I ). More of the apical Ki67+ cells in the NV-cKO were negative for BrdU at 24 hr after BrdU injection compared to control, suggesting the increase of Ki67+ cells was not due to increased division of BrdU-incorporated actively dividing cells ( Figure S5H ).
Furthermore, we labeled the slowly dividing pre-B1 cells by repeated BrdU injection at E10 and examined the brain at E17.5 as described above ( Figure 2D ). BrdU-LRCs were significantly decreased in NV-cKO compared to control (Figures 5C and 5D) . Similarly, by BrdU injection at E16-E18 once per day for 3 days, we found that BrdU-LRCs in the V-SVZ wholemount of NV-cKO mice were reduced to almost half the number in control mice at P21 (Figures 5E-5G ). We found that the number of Ki67+ cells was also decreased significantly in the cKO wholemount at P21 ( Figure 5G) . Notably, the percentage of Ki67+ cells in the brightly labeled BrdU-LRC+ cell population was significantly reduced in the KO wholemount compared to control (Figure S5J) , suggesting that activation of BrdU-LRCs could be impaired. The lost BrdU-LRCs could be ependymal cells; however, we did not observe disruption of the ependymal layer (not shown). Hence, the reduction in BrdU-LRCs was likely due to a decrease in slowly dividing RGCs.
Loss of VCAM1 Leads to Reduced Regeneration of the Adult V-SVZ and Adult BrdU-LRCs
The adult SVZ is capable of regeneration after infusion of the antimitotic drug cytosine-b-D-Arabinofuranoside (AraC), which depletes actively dividing cells but spares quiescent type B cells (E and F) The distribution and quantification of pNeuroD1-mCherry+ (red) and GFP+ (green) cells in the cortex at 2 days after IUE (E14.5/E16.5) of control-GFP (Ctrl) or VCAM1shRNA (V-sh) plasmid. (G) Diagram of the constructs for expression of a full-length wild-type VCAM1 (VCAM1), an intracellular domain-truncated form (DCyt19), and a full-length form with a point mutation in the intracellular domain (S730A). in the V-SVZ (Doetsch et al., , 1999b . To test whether VCAM1 is responsible for the regenerative capacity, we treated the adult mice with 2% AraC using osmotic mini-pumps for 6 days and sacrificed the mice 24 hr after removal of the minipumps ( Figure 5H ). Consistent with a previous report (Doetsch et al., 1999b) , we did not detect DCX+ type A cells in the V-SVZ of the control brain sections, confirming efficient ablation of dividing cells by AraC. However, many Ki67+ cells had already appeared, indicating that the regeneration process has started.
We found that far fewer Ki67+ cells were present in the NVcKO V-SVZ at this time point, a 43% reduction compared to control ( Figures 5I and 5J ). This result indicates that VCAM1 is required for maintaining the quiescent cells that are capable of regenerating the adult SVZ after AraC treatment. Consistently, a 4-week chase after 5-day pulse of BrdU injection showed a significant loss of BrdU-LRCs in the adult SVZ of NV-cKO mice compared to control, and the number of BrdU+ cells was also reduced in the OB (Figures 5K-5M ). We also found that loss of VCAM1 reduced the percentage of SOX2+ and SOX2+GFAP+ cells with radial morphology in the NV-cKO V-SVZ ( Figures  S5K and S5L ).
Overexpression of VCAM1 in the Dorsal Forebrain Promotes RGC Identity and Segregation of pre-B1 NSCs As loss of VCAM1 in the cortical V-SVZ is accompanied by a reduction of NSCs in this domain, we hypothesized that overexpression of VCAM1 in the cortical V-SVZ might maintain NSCs there. To test this hypothesis, we electroporated the VCAM1 overexpression plasmid (V-over) into the cortical VZ at E14.5. Overexpression of VCAM1 for a short term (2 days) did not significantly affect the number of Ki67+ cells in the V-SVZ ( Figures S6A  and S6B ). Interestingly, we observed more radial processes of VCAM1-overexpressing cells attaching to the meninges compared to control ( Figure 6A ). Moreover, after a longer time of VCAM1 overexpression (from E14.5 to P7), we found that persistent VCAM1 expression kept more progenitor cells in the V-SVZ compared to control ( Figures 6B-6D ). To normalize for transfection efficiency, we quantified the ratio of GFP+ cells in the V-SVZ to the total GFP+ cells in the cortical plate and V-SVZ zone. Of the GFP+ cells, 12.7% were detected in the V-SVZ after overexpression of VCAM1, compared to 7.6% in the control group ( Figure 6B ). The GFP+ cells retained in the V-SVZ were positive for SOX2 (65% ± 17%), and only 21% ± 12% were Ki67+ ( Figures 6C and 6D ). Some were also Pax6+ ( Figure S6C ). It is possible that lack of GFP+ cells in the V-SVZ of control group was due to dilution of the plasmids after multiple rounds of division. Nonetheless, the retention of VCAM1-expressing GFP+ cells in the postnatal cortical V-SVZ indicates that prolonged expression of VCAM1 allows apical progenitor cells to stay in a quiescent and undifferentiated state. To further analyze the fate of VCAM1-overexpressing cells in the V-SVZ, we adopted a binary piggyBac transposase plasmid system to label the entire lineage of VCAM1-expressing cells. This system, consisting of a piggyBac donor plasmid (PB-GFP) and a helper plasmid encoding piggyBac transposase (PBase), produces stable integration of donor transgenes into the entire progenitor lineage when transfected by IUE into cortical progenitor cells (Chen et al., 2015) . When analyzed at E18.5, overexpression of VCAM1 (PB-VCAM1) increased Pax6+Tbr2À cells in the VZ/SVZ (from 30.99% ± 2.66% to 42.75% ± 3.89%) while reducing Tbr2+Pax6À cells (from 14.81% ± 2.32% to 2.22% ± 2.22%) compared to the control plasmid (PB-GFP), consistent with its role in maintaining radial glial identity ( Figures 6E, 6F , and S6D). By P9, in addition to GFP+ cells with typical neuronal morphology found in the upper layer, many GFP+ cells with distinct glial morphology were also present in the cortical plate and corpus callosum in both groups ( Figure 6G) . The neuronal or glial identity was confirmed with staining for cell-type-specific markers (Satb2 for neurons, GFAP for astrocytes, and Olig2 for oligodendrocytes), which correlated well with morphological features ( Figure S6E ). More GFP+ cells were found in the V-SVZ using PB-GFP plasmid compared to that using episomal plasmids, confirming the persistence of the transgene in the entire lineage as reported by Chen et al., 2015 . Consistently, the ratio of GFP intensity in the V-SVZ to that in the cortical plate was higher in PB-VCAM1 group compared to control ( Figure 6H ). We noticed that some GFAP+GFP+ cells in the V-SVZ still had radial processes ( Figure 6J ), which were likely RGCs. When a BrdU injection was given to the mice at P2, we found that among the BrdU+ cells in the cortical plate, almost all were negative for Satb2. These cells were likely glial cells by morphology, indicating cortical neurons were not born at P2. Interestingly, PB-VCAM1-transfected cells generated fewer cortical neurons than control ( Figure 6I ), suggesting these VCAM1-overexpressing cells did not contribute significantly to cortical neurogenesis after birth.
Given that OB neurons share a lineage relationship with cortical glial cells, but not cortical neurons after E15.5 (Fuentealba et al., 2015), we examined the OB for GFP+ cells. Indeed, GFP+ neurons were detected in the granular cell layer of the OB ( Figure 6G ), indicating that PB-VCAM1 cells were capable of generating OB neurons. However, persistent overexpression of VCAM1 did not significantly increase the percentage of BrdU+ GFP+ neurons ( Figures 6K and 6L) . By 2 months after birth, we still observed GFAP+ and SOX2+ PB-VCAM1-GFP cells in the V-SVZ, some with radial processes (Figure S6F ), suggesting overexpression of VCAM1 preserves NSCs in the V-SVZ, although we could not exclude the possibility of these cells being astrocytes, as both GFAP and SOX2 are expressed in astrocytes in the adult brain. 
GSK3b/b-Catenin Signaling Mediates VCAM1 Function in Active Dividing Cortical RGCs
Wnt signaling is known to play an important role in regulating NSC self-renewal, proliferation, and differentiation (Adachi et al., 2007; Hirota et al., 2016) . To investigate whether VCAM1 affects b-catenin signaling in active RGCs, we constructed a canonical Wnt signaling reporter plasmid, BAT-mCherry (b-catenin-activated transgene-mCherry), based on the BAT-gal construct ( Figure S7A) , which expresses the reporter protein under the control of seven TCF/LEF-binding sites. When E14.5 cortical RGCs were co-transfected with BAT-mCherry and VCAM1-related plasmids, we found that V-sh reduced while V-over increased BAT-mCherry+ cell number at E16.5 ( Figures  7A and 7B) . DCyt19 or S730A plasmid also dramatically reduced the number of BAT-mCherry+ cells similar to the V-sh plasmid ( Figures S7C and S7D ). These results indicate that VCAM1 and its intracellular domain are required for b-catenin signaling in active cortical RGCs.
To further confirm the involvement of b-catenin pathway in VCAM1 function, we constructed a constitutively active b-catenin construct (DN90-b-catenin) ( Figure S7E ). Co-transfection of DN90-b-catenin with V-sh, DCyt19, or S730A in E14.5 cortical RGCs reversed the reduction in the percentage of Ki67+ cells caused by VCAM1 knockdown or intracellular domain mutants ( Figures 7D and 7F) . A GSK3b kinase-dead plasmid (GSK-KD), which competitively inhibits GSK3b, leading to activated b-catenin signaling (Zeng et al., 2005) (Figures S7B and S7F) , also reversed the defects in proliferation and differentiation induced by altered VCAM1 signaling ( Figures 7C and 7E) . Furthermore, we found that total GSK3b expression was increased in VCAM1 cKO embryonic cortex compared to control, but the level of phospho-GSK3b (pGSK3b, Ser9), an inactive form lacking the ability to phosphorylate its substrates (Zeng et al., 2005) , was reduced nearly 50% as shown by western blot ( Figure 7G ). Similarly, in cortical neurospheres transduced with V-sh, DCyt19, or S730A lentiviruses, the level of pGSK3b (Ser9) was reduced compared to control ( Figure 7G ). Conversely, overexpression of VCAM1 significantly increased the pGSK3b (Ser9) level ( Figure S7G ). These results indicate that VCAM1 regulates cortical RGC development through GSK3b/b-catenin signaling.
To test whether b-catenin signaling is necessary for VCAM1 function, we silenced b-catenin expression using an shRNA construct. Co-transfection of V-over and b-catenin-shRNA disrupted the effect of VCAM1 overexpression, promoting the cells leaving the VZ/SVZ (Figures S7H and S7I ).
Time and Location-Dependent Effects of VCAM1 on b-Catenin Pathway
The differential effects of VCAM1 on active RGCs and slowly dividing pre-B1 RGCs suggest that VCAM1 signaling could be different in these two populations. Given that more slowly dividing pre-B1 RGCs are located in the LGE region, we investigated whether VCAM1 signaling in this region differed from the dorsal cortex as we described above. We found that very few cells were BAT-mCherry positive when IUE into the LGE was performed at E14.5 and examined at E16.5 (less than 2% of GFP+ cells were BAT-mCherry+, not shown), suggesting that Wnt signaling is not active in the LGE progenitor cells, consistent with a restriction of Wnt signaling to the dorsal forebrain during early neurogenic stage (Backman et al., 2005; Bowman et al., 2013) . Interestingly, when IUE was performed at E16.5 in the LGE, we found that in contrast to the effect in the cortex, V-sh increased while V-over did not significantly change the number of BAT-mCherry+ cells in the LGE V-SVZ ( Figure S8A ). In addition, phosphorylation of b-catenin at Ser552 (pb-catenin Ser552), which induces b-catenin accumulation in the nucleus, was decreased in the VCAM1-deficient cortex but increased in the GE as shown by western blot (Figures 8A and 8B) . However, the levels of GSK3b and phosphorylated GSK3b were not changed ( Figure S8B) .
We further investigated the long-term effect of VCAM1 alteration on b-catenin signaling in the GE. In control groups many GFP+ cells appeared in the OB at P7, indicating electroporated cells differentiated and had migrated to the OB. The ratio of GFP+ cells in the LGE V-SVZ to GFP+ cells in the OB was decreased after V-sh knockdown but increased after V-over compared to control (Figures 8C-8I ). For the cells that were still in the V-SVZ, more GFP+ cells were BAT-mCherry+ in the V-sh group, indicating b-catenin signaling was activated in these cells ( Figures 8C and 8I ). In contrast, we observed an increased retention of GFP+ cells along the ventricular surface of the lateral wall of the lateral ventricle in the V-over group compared to control ( Figures 8F and 8G) . Of GFP+ cells in the V-SVZ, 76.6% were Sox2+ and 79.3% were Ki67À, while some were also positive for Nestin and GFAP (Figures S8C-S8E) . Interestingly, we did not find a significant change in b-catenin signaling in cortical V-SVZ after the long term ( Figure S8F ), indicating contextdependent regulation of VCAM1 on b-catenin signaling.
DISCUSSION
NSCs are actively proliferating in the embryo to contribute to brain histogenesis, while a substantial proportion of them become quiescent during the late embryonic stage and persist in the adult brain (Fuentealba et al., 2015; Furutachi et al., 2015) . In this study, we demonstrate that persistent expression of VCAM1 is required for maintenance of the embryonic origin of postnatal and adult NSC population in the V-SVZ, through a biphasic mechanism. VCAM1 maintains the RGC population during the active proliferating stage and preserves the slowly dividing cells during the quiescent stage. Moreover, our findings indicate that the intracellular domain of VCAM1 is important for keeping neural progenitor cells undifferentiated in vivo through differential regulation of b-catenin signaling, identifying a novel VCAM1 intracellular signaling pathway ( Figure 8J ).
Temporal and Spatial Dynamics of VCAM1 Expression
Our expression analysis revealed that VCAM1 is initially expressed in most RGCs on the ventricular surface, then gradually segregated into the slowly dividing NSCs, indicating its expression is tightly controlled in NSCs. The spatially segregated pattern of VCAM1 in a subpopulation of RGCs is reminiscent of the pattern of proneural clusters created by Notch-Delta-mediated lateral inhibition during Drosophila neuroblast delamination (Jan and Jan, 1994) . Interestingly, it has been shown that Notch activation stimulates VCAM1 expression in endothelial cells , (E), and (F), one-way ANOVA followed by Bonferroni's post test; (G), unpaired t test. (Verginelli et al., 2015) , glioblastoma stem cells (Guichet et al., 2015) , and RGCs (Kawaguchi et al., 2008) , which raises the idea that Notch-VCAM1 interaction could lead to segregation of the pre-B1 RGCs from other RGCs, in a process akin to lateral inhibition. A clearer understanding of the relationship between VCAM1 and Notch signaling in this context will be the subject of further study.
Notably, the subcellular distribution of VCAM1 also changes from mostly uniform expression on the cell membrane to being more localized in the apical and basal endfeet of radial glia.
This change is more evident in the GE region. It is conceivable that the apical membrane tethering of VCAM1 might be important for holding apical neural stem and progenitor cells along the ventricular surface, as we have demonstrated that blocking VCAM1 in the adult brain leads to disruption of the V-SVZ cytoarchitecture (Kokovay et al., 2012) . Enrichment of VCAM1 on the ventricular side is coincident with the decrease in proliferative rate of VCAM1-expressing cells. Perhaps as the NSCs become quiescent, it is necessary to develop a mechanism to keep them sensitive and responsive to the ventricular Scale bars: (D), (F), and (H), 100 mm; (E), (G), and (I), 75 mm; (E'-E'''), (G'-G'''), and (I'-I''), 15 mm. Data represent mean ± SEM, n = 3 experiments for (B) and 3 embryos in each group for (C). *p < 0.05; **p < 0.01 (B, unpaired t test; D, one-way ANOVA then Dunnett's post test).
environment. For example, inflammation leads to cerebrospinal fluid accumulation of cytokines IL1b and TNF, which are known VCAM1 inducers (Osborn et al., 1989) .
Persistent VCAM1 Expression Is Associated with the Developmental Transition of NSCs from Embryonic Stage to Adult, Regardless of Proliferative Status During brain development, NSCs are contained within the lineage from neuroepithelial cells to RGCs to postnatal/adult B1 cells (Alvarez-Buylla et al., 2001; Kriegstein and Alvarez-Buylla, 2009 ). We know very little about how a subpopulation of RGCs are selected to become pre-B1 cells and maintained during development. VCAM1 expression becomes enriched in a specific set of embryonic progenitor cells after mid-gestation stage, coincident with the appearance of pre-B1 cells (our results and Fuentealba et al., 2015) . The pre-B1 cells continue to express VCAM1 while developing into mature type B cells, which are anchored in the pinwheel center in the adult SVZ, as we have previously shown (Kokovay et al., 2012) . Hence, VCAM1 expression is retained throughout the continuum of embryonic RGCs to pre-B1 cells and then to the adult quiescent NSCs. We propose that persistent VCAM1 expression primes embryonic RGCs to develop into the pre-B1 cell lineage and selectively follows the NSC lineage transition from embryo to adult. We also show that embryonic VCAM1-expressing cells are capable of generating neurons and glia, as well as cells preserved in the V-SVZ. Future work to genetically trace VCAM1-expressing neural cells would help further understand the cell-cycle kinetics, division pattern, transition, and maintenance of this subpopulation of progenitor cells. As VCAM1 is also expressed in long-term repopulating hematopoietic stem cells, mesenchymal stem cells, myoblasts in the embryo, and the quiescent stem cell-like satellite cells in adult muscle (Lai et al., 2005; Shi and Garry, 2006) , this may provide insight on the principle of the lineage progression and maintenance of stem cells in other systems.
The Functional Role of VCAM1 in Neural Progenitor Cells Despite its known expression in stem cells, whether VCAM1 plays a functional role remains a question. Our results suggest that enduring expression of VCAM1 is functionally responsible for maintaining stem cell population into the adulthood. Intriguingly, the effect of VCAM1 on stem cell proliferation is context dependent: VCAM1 is required for RGC's proliferation when cortical and GE cells are actively dividing, while VCAM1 is necessary for keeping the slowly dividing apical RGCs in the GE quiescent. As persistent VCAM1 expression is associated with NSCs throughout development, it is likely that VCAM1 confers stem cell property, rather than a direct action on cell division mechanisms. Hence, VCAM1 expression is important to maintain the stem cell state that is appropriate to the time and place these cells belong to, independent of their proliferative behavior. Similarly, it has been shown that activation of Notch signaling in neural progenitor cells promotes radial glia fate regardless of proliferative status (Gaiano et al., 2000) . The dorsal-ventral differential expression pattern of VCAM1 and the KO phenotype is reminiscent of that of p57, a key factor in generating the slowly dividing subpopulation of embryonic neural progenitor cells (Furutachi et al., 2015) . These lines of evidence suggest the identity of NSCs could be regulated independently or in combination with the cell-cycle machinery.
Context-Dependent VCAM1 Signaling in Neural Progenitor Cells VCAM1 is a membrane protein consisting of several extracellular Ig-like domains, a single transmembrane domain, and a 19 amino acid carboxy-terminal cytoplasmic domain. The cytoplasmic domain of VCAM1 is highly conserved among many mammalian species with 100% identical amino acid sequence and can elicit an ''outside-in'' signal transduction in endothelial cells (Cook-Mills et al., 2011) . We found that VCAM1 intracellular signaling in RGCs is mediated through b-catenin signaling, which has not been shown before. It is not clear yet how b-catenin is affected by VCAM1. During forebrain development, inhibition of b-catenin by GSK3b is suppressed in active proliferating stage but increased at later stages (Azim et al., 2014; Kim et al., 2009) . We found that both the inhibitory GSK-KD construct and active form of b-catenin can rescue the defects in proliferating cortical RGCs caused by disruption of VCAM1 signaling, implying VCAM1 promotes b-catenin signaling in actively dividing cortical RGCs through inhibition of GSK3b. Intriguingly, VCAM1 is required to suppress b-catenin signaling in the GE after the embryonic origins of adult NSCs are set aside, suggesting context-dependent regulation of Wnt signaling on NSC development. Indeed, the effect of Wnt signaling on NSCs depends on other factors present at specific stages and locations (Kuwahara et al., 2010; Langseth et al., 2010; Marinaro et al., 2012; Ortega et al., 2013) . For example, the presence of the b-catenin interactor Homeodomain-interacting protein kinase-1 gene (Hipk1) changes the proliferative effect of b-catenin to differentiationpromoting (Marinaro et al., 2012) . Perhaps the differential combinatory act of Wnt ligands, receptors, and modulators in the dorsal and ventral forebrain contributes to the different outcomes of VCAM1 on Wnt signaling. As NSCs are heterogeneous in terms of progenitor cell types, regional lineage specificity, and transcriptome profile (Azim et al., 2015; Bowman et al., 2013; Lim and Alvarez-Buylla, 2016; Taverna et al., 2014) , other temporal or dorsal-ventral differentially expressed genes and epigenetic modifications might also contribute to the difference in VCAM1-conferred NSC behavior.
In summary, our work has revealed the temporal and spatial dynamics of VCAM1 expression and the functional importance of VCAM1 in maintaining the continuum of NSCs while they switch from an active proliferative state to a quiescent state. We also identified a novel link between VCAM1 and GSK3b/ b-catenin pathway in a context-dependent manner. As VCAM1 is also expressed in other stem cells, such as HSC and muscle satellite cells, this novel mechanism might have a broad implication in regulation of stem cell quiescence.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Animals and generation of VCAM1 conditional knockout mice Mice were bred and maintained in the animal care facility at Center of Biomedical Analysis in Tsinghua University. All animal protocols used in this study were approved by the IACUC (Institutional Animal Care and Use Committee) of Tsinghua University and performed in accordance with guidelines of the IACUC. The laboratory animal facility has been accredited by AAALAC (Association for Assessment and Accreditation of Laboratory Animal Care International). All transgenic mouse lines were from the Jackson Laboratory. Neural-specific VCAM1 conditional knockout mice were generated by breeding Emx1-IRES-Cre (B6.129S2-Emx1 tm1(cre)Krj/J , Stock No: 005628) (Gorski et al., 2002) or Nestin-Cre (B6.Cg-TgN(Nes-cre) 1Kln)/J , Stock No: 003771) (Tronche et al., 1999) (Muzumdar et al., 2007) . We confirmed that Emx1-Cre mediated specific recombination in the dorsal telencephalon ( Figure S2C ), while Nestin-Cre resulted in recombination in most areas of the central nervous system, including the dorsal cerebral cortex and the ventral forebrain, but not in blood vessels ( Figure S2D and VCAM1 fl/fl mice were used as the control mice. ICR mice were obtained from Vital River Laboratory Animal Technology Company (Beijing, China). For staging of embryos, mid-day of the vaginal plug identified was calculated as embryonic day 0.5 (E0.5). All adult mice used were 6-12 weeks of age and the ages of postnatal pups were specified in the text.
Neural stem cell culture For the adherent culture, embryos from timed pregnant ICR mouse were dissected and cerebral cortices or GE were removed from the brain. Tissues were dissociated and cultured in serum-free N-2/B-27/DMEM medium with 10 ng/ml FGF2 (Life Tech) in poly-Llysine (PLL, Sigma)-coated Terasaki (Nunc) or multi-well plates (Costar) for 3-7 days as described previously (Qian et al., 2000; Shen et al., 2004) . For neurosphere assay, single dissociated cortical or GE cells were cultured in serum-free medium at 3000 cells/ml with 20 ng/ml FGF2 and 20 ng/ml EGF (Life Tech) in ultra-low attachment 6-well plates (Costar) for 7 days. Neurospheres were dissociated enzymatically into single cells and cultured for 7 days for each passage. For cell fate assessment, neurospheres were collected, transferred to PLL-coated plates to adhere, and mitogen was removed to stimulate differentiation; the cells were fixed 5-7 d later and immunostained.
In utero electroporation (IUE) Timed-pregnant mice were anesthetized by isoflurane and put on a heated pad. The uterine horn was exposed and 0.5-1 mL of plasmid solution (2-3 mg/ml) was injected into the lateral ventricle of the embryonic brain with a fine glass micropipette. Embryos were then clamped between 5 mm-diameter tweezers-type disc electrodes (LF650P5; BEX) and for bigger embryos (> E16), a homemade 10 mm-diameter disc electrodes were used. Five 50 ms, 36 V electrical pulses at an interval of 999 ms were given using an electroporator (CUY21VIVO-SQ; BEX). Uterine horns were then placed back into the abdominal cavity to allow the embryos to continue normal development. To observe the phenotype, embryos were isolated and fixed in 4% PFA in PBS two-four hours post in utero electroporation (DPI) or at postnatal stages. In rescue experiments of VCAM1 knockdown, a shRNA plasmid targeting the 3 0 -UTR of VCAM1 and a VCAM1CDS overexpression plasmid (VCAM1CDS) were mixed at 1:1 ratio and injected into the lateral ventricle. This ratio was used in other co-electroporation experiments including using GSK-KD and DN90 to rescue the phenotype of DCyt and S730A.
Bromodeoxyuridine (BrdU) labeling and detection BrdU (50 mg/kg) was injected intra-peritoneally into pregnant mice 30 min before sacrifice to label S-phase cells. To examine cellcycle exit, BrdU was injected into pregnant mice 24 hr before sacrifice. The embryonic brains were fixed and cryoprotected. Frozen sections of embryonic brain were processed for detection of BrdU (after 2N HCl treatment) and Ki67 using immunofluorescence. To perform the embryonic pulse-chase experiments, BrdU was injected once a day for 3 days from E15.5 to E17.5 or from E16.5 to E18.5. V-SVZ wholemounts were processed and stained for BrdU at P18 or P21.
Labeling of slowly dividing cells: BrdU was injected into pregnant mice 4 times at 2hr interval at E10.5. Embryos were removed and fixed at E17.5 for BrdU staining.
Adult BrdU long term label-retaining: BrdU (50 mg/kg) was injected intra-peritoneally into adult mice for 5 days and the mice were sacrificed 28 days after the last injection.
